Sangamo Therapeutics
Stock Forecast, Prediction & Price Target
Sangamo Therapeutics Financial Estimates
Sangamo Therapeutics Revenue Estimates
Sangamo Therapeutics EBITDA Estimates
Sangamo Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $110.70M N/A | $111.29M 0.54% | $176.23M 58.34% | Avg: $70.15M Low: $32.69M High: $141.24M avg. -60.19% | Avg: $88.14M Low: $37.22M High: $185.98M avg. 25.64% | Avg: $204.62M Low: $86.41M High: $431.72M avg. 132.13% | Avg: $370.28M Low: $156.37M High: $781.24M avg. 80.95% |
Net Income
% change YoY
| $-178.29M N/A | $-192.27M -7.84% | $-257.83M -34.09% | Avg: $-46.57M Low: $-108.15M High: $36.63M avg. 81.93% | Avg: $-47.47M Low: $-78.49M High: $-1.74M avg. -1.94% | Avg: $25.11M Low: $6.25M High: $61.36M avg. 152.90% | Avg: $97.68M Low: $24.32M High: $238.63M avg. 288.88% |
EBITDA
% change YoY
| $-183.33M N/A | $-201.28M -9.78% | $-87.42M 56.56% | Avg: $-63.45M Low: $-127.76M High: $-29.57M avg. 27.41% | Avg: $-79.73M Low: $-168.22M High: $-33.67M avg. -25.64% | Avg: $-185.08M Low: $-390.50M High: $-78.16M avg. -132.13% | Avg: $-334.92M Low: $-706.65M High: $-141.44M avg. -80.95% |
EPS
% change YoY
| -$1.23 N/A | -$1.25 -1.62% | -$1.48 -18.4% | Avg: -$0.22 Low: -$0.62 High: $0.21 avg. 85.17% | Avg: -$0.19 Low: -$0.45 High: -$0.01 avg. 14.15% | Avg: $0.14 Low: $0.04 High: $0.35 avg. 176.46% | Avg: $0.56 Low: $0.14 High: $1.37 avg. 288.88% |
Operating Expenses
% change YoY
| $294.03M N/A | $312.58M 6.30% | $450.23M 44.03% | Avg: $35.34M Low: $16.47M High: $71.16M avg. -92.14% | Avg: $44.41M Low: $18.75M High: $93.70M avg. 25.64% | Avg: $103.09M Low: $43.53M High: $217.51M avg. 132.13% | Avg: $186.55M Low: $78.78M High: $393.60M avg. 80.95% |
FAQ
What is Sangamo Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 130.44% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -108.15M, average is -46.57M and high is 36.63M.
What is Sangamo Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 44.63% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $32.69M, average is $70.15M and high is $141.24M.
What is Sangamo Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 141.17% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$0.62, average is -$0.22 and high is $0.21.
What is the best performing analyst?
In the last twelve months analysts have been covering Sangamo Therapeutics stock. The most successful analyst is Andreas Argyrides whose win rate is 100%. He has correctly predicted 1/1 price targets.